Quantitative gene expression in Budd-Chiari syndrome: a molecular approach to the pathogenesis of the disease

Background: Budd-Chiari syndrome (BCS) is associated with parenchymal changes leading to major architecture remodelling. In order to gain further insight into the pathogenesis of BCS, we investigated expression of a set of genes involved in the course of chronic liver diseases. Methods: Quantitative expression of 35 selected genes involved in extracellular matrix regulation, growth factors, and angiogenesis was investigated in 13 cases of BCS and compared with 10 normal livers and 13 cirrhosis cases by real time reverse transcription-polymerase chain reaction. Differential gene expression was considered significant for genes showing at least a twofold variation, with p<0.05. Results: Expression of 14 genes was significantly increased in BCS versus normal liver, with the highest increase in superior cervical ganglion 10 (SCG10) gene. BCS cases were classified according to their evolution and morphological pattern as either acute or chronic in six and seven cases, respectively. Unsupervised hierarchical clustering of acute and chronic BCS cases on the basis of similarity in gene expression pattern led to distinction between the two groups. Expression of three genes was significantly different in acute versus chronic BCS (increase in matrix metalloproteinase 7 and SCG10, decrease in thrombospondin-1 for chronic BCS). Seventeen and 10 genes, mainly involved in extracellular matrix and vascular remodelling, were significantly deregulated in acute BCS versus normal liver and cirrhosis, respectively. Conclusion: These results show that BCS cases display a specific gene expression profile that is different from that of normal liver and cirrhosis; the molecular configuration of BCS can be readily distinguished by its evolution and morphological pattern.

[1]  I. Laurendeau,et al.  A role for thrombin in liver fibrosis , 2004, Gut.

[2]  J. Egido,et al.  Connective Tissue Growth Factor Is a Mediator of Angiotensin II–Induced Fibrosis , 2003, Circulation.

[3]  J. Wilcox,et al.  Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. , 1998, The American journal of pathology.

[4]  T. Asselah,et al.  Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. , 2005, Virology.

[5]  E. Cholongitas,et al.  Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis , 2003, Gut.

[6]  V. Paradis,et al.  A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia. , 2003, Gastroenterology.

[7]  D. Wendum,et al.  Hypoxia‐induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis , 2002, Hepatology.

[8]  Gary R. Grotendorst,et al.  Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10 , 1991, The Journal of cell biology.

[9]  R. Goldin,et al.  Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection , 2002, Gut.

[10]  S. Friedman,et al.  Liver fibrosis -- from bench to bedside. , 2003, Journal of hepatology.

[11]  V. Paradis,et al.  Expression of connective tissue growth factor in experimental rat and human liver fibrosis , 1999, Hepatology.

[12]  David J. Anderson,et al.  Molecular probes for the development and plasticity of neural crest derivatives , 1985, Cell.

[13]  A. Sobel,et al.  SCLIP: A Novel SCG10‐Like Protein of the Stathmin Family Expressed in the Nervous System , 1998, Journal of neurochemistry.

[14]  F. Carnot,et al.  Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C. , 2001, Human pathology.

[15]  P. Nawroth,et al.  Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  I. Wanless,et al.  Pathology of the liver in budd‐chiari syndrome: Portal vein thrombosis and the histogenesis of veno‐centric cirrhosis, veno‐portal cirrhosis, and large regenerative nodules , 1998, Hepatology.

[17]  V. Vilgrain,et al.  Arterial and portal circulation and parenchymal changes in Budd‐Chiari syndrome: A study in 17 explanted livers , 2003, Hepatology.

[18]  Gary R. Grotendorst,et al.  Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. , 1996, The Journal of investigative dermatology.

[19]  M. Gimbrone,et al.  Inducible Endothelial Functions in Inflammation and Coagulation , 1987, Seminars in thrombosis and hemostasis.

[20]  L. Lindgren,et al.  CYCLOSPORINE INDUCES MYOCARDIAL CONNECTIVE TISSUE GROWTH FACTOR IN SPONTANEOUSLY HYPERTENSIVE RATS ON HIGH-SODIUM DIET1 , 2001, Transplantation.

[21]  F. Colina,et al.  Focal hyperplastic hepatocellular nodules in hepatic venous outflow obstruction: a clinicopathological study of four patients and 24 nodules , 2004, Histopathology.

[22]  B. Trueb,et al.  Mechanical stress is required for high-level expression of connective tissue growth factor. , 2002, Experimental cell research.

[23]  Gary R. Grotendorst,et al.  Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. , 1996, The Journal of investigative dermatology.

[24]  R. Chambers,et al.  Thrombin Is a Potent Inducer of Connective Tissue Growth Factor Production via Proteolytic Activation of Protease-activated Receptor-1* , 2000, The Journal of Biological Chemistry.

[25]  L. Thal,et al.  Blood Levels of Alpha-1-Antichymotrypsin and Risk Factors for Alzheimer’s Disease: Effects of Gender and Apolipoprotein E Genotype , 2000, Dementia and Geriatric Cognitive Disorders.

[26]  V. Paradis,et al.  High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: A potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis , 2001, Hepatology.

[27]  M. Kage,et al.  Proposal of a new nomenclature for budd‐chiari syndrome: Hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion , 1998, Hepatology.

[28]  J. Yee,et al.  Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. , 2000, Journal of the American Society of Nephrology : JASN.

[29]  S. Milani,et al.  Expression of the thrombin receptor in human liver: Up‐regulation during acute and chronic injury , 1998, Hepatology.

[30]  P. Curmi,et al.  Stathmin Family Proteins Display Specific Molecular and Tubulin Binding Properties* , 2001, The Journal of Biological Chemistry.